Literature DB >> 22249911

The use of 2,2'-dithiobis(5-nitropyridine) (DTNP) for deprotection and diselenide formation in protected selenocysteine-containing peptides.

Alayne L Schroll1, Robert J Hondal, Stevenson Flemer.   

Abstract

In contrast to the large number of sidechain protecting groups available for cysteine derivatives in solid phase peptide synthesis, there is a striking paucity of analogous selenocysteine Se-protecting groups in the literature. However, the growing interest in selenocysteine-containing peptides and proteins requires a corresponding increase in availability of synthetic routes into these target molecules. It therefore becomes important to design new sidechain protection strategies for selenocysteine as well as multiple and novel deprotection chemistry for their removal. In this paper, we outline the synthesis of two new Fmoc selenocysteine derivatives [Fmoc-Sec(Meb) and Fmoc-Sec(Bzl)] to accompany the commercially available Fmoc-Sec(Mob) derivative and incorporate them into two model peptides. Sec-deprotection assays were carried out on these peptides using 2,2'-dithiobis(5-nitropyridine) (DTNP) conditions previously described by our group. The deprotective methodology was further evaluated as to its suitability towards mediating concurrent diselenide formation in oxytocin-templated target peptides. Sec(Mob) and Sec(Meb) were found to be extremely labile to the DTNP conditions whether in the presence or absence of thioanisole, whereas Sec(Bzl) was robust to DTNP in the absence of thioanisole but quite labile in its presence. In multiple Sec-containing model peptides, it was shown that bis-Sec(Mob)-containing systems spontaneously cyclize to the diselenide using 1 eq DTNP, whereas bis-Sec(Meb) and Sec(Bzl) models required additional manipulation to induce cyclization.
Copyright © 2012 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249911      PMCID: PMC3437994          DOI: 10.1002/psc.1430

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  18 in total

1.  Selenocysteine in native chemical ligation and expressed protein ligation.

Authors:  R J Hondal; B L Nilsson; R T Raines
Journal:  J Am Chem Soc       Date:  2001-05-30       Impact factor: 15.419

2.  A novel RNA structural motif in the selenocysteine insertion element of eukaryotic selenoprotein mRNAs.

Authors:  R Walczak; E Westhof; P Carbon; A Krol
Journal:  RNA       Date:  1996-04       Impact factor: 4.942

3.  Synthesis of selenocysteine peptides and their oxidation to diselenide-bridged compounds.

Authors:  D Besse; L Moroder
Journal:  J Pept Sci       Date:  1997 Nov-Dec       Impact factor: 1.905

4.  Synthesis of selenium-containing peptides.

Authors:  D Theodoropoulos; I L Schwartz; R Walter
Journal:  Biochemistry       Date:  1967-12       Impact factor: 3.162

5.  2,2'-Dithiobis(5-nitropyridine) (DTNP) as an effective and gentle deprotectant for common cysteine protecting groups.

Authors:  Alayne L Schroll; Robert J Hondal; Stevenson Flemer
Journal:  J Pept Sci       Date:  2011-11-14       Impact factor: 1.905

Review 6.  Local activation and inactivation of thyroid hormones: the deiodinase family.

Authors:  J Köhrle
Journal:  Mol Cell Endocrinol       Date:  1999-05-25       Impact factor: 4.102

Review 7.  Physiological functions of thioredoxin and thioredoxin reductase.

Authors:  E S Arnér; A Holmgren
Journal:  Eur J Biochem       Date:  2000-10

8.  Synthetic study on selenocystine-containing peptides.

Authors:  T Koide; H Itoh; A Otaka; H Yasui; M Kuroda; N Esaki; K Soda; N Fujii
Journal:  Chem Pharm Bull (Tokyo)       Date:  1993-03       Impact factor: 1.645

Review 9.  Selenoprotein P. A selenium-rich extracellular glycoprotein.

Authors:  R F Burk; K E Hill
Journal:  J Nutr       Date:  1994-10       Impact factor: 4.798

10.  Metalloselenonein, the selenium analogue of metallothionein: synthesis and characterization of its complex with copper ions.

Authors:  T Oikawa; N Esaki; H Tanaka; K Soda
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

View more
  11 in total

1.  Solid-phase synthesis of reduced selenocysteine tetrapeptides and their oxidized analogs containing selenenylsulfide eight-membered rings.

Authors:  Ludger A Wessjohann; Alex Schneider; Goran N Kaluđerović; Wolfgang Brandt
Journal:  Mol Divers       Date:  2013-06-01       Impact factor: 2.943

2.  Design of a selenylsulfide-bridged EGFR dimerization arm mimic.

Authors:  Laura E Hanold; Christopher P Watkins; Norman T Ton; Peter Liaw; Aaron M Beedle; Eileen J Kennedy
Journal:  Bioorg Med Chem       Date:  2015-03-20       Impact factor: 3.641

3.  2,2'-Dipyridyl diselenide: A chemoselective tool for cysteine deprotection and disulfide bond formation.

Authors:  Emma J Ste Marie; Robert J Hondal
Journal:  J Pept Sci       Date:  2019-12-19       Impact factor: 1.905

4.  Site-Specific Incorporation of Selenocysteine Using an Expanded Genetic Code and Palladium-Mediated Chemical Deprotection.

Authors:  Jun Liu; Feng Zheng; Rujin Cheng; Shanshan Li; Sharon Rozovsky; Qian Wang; Lei Wang
Journal:  J Am Chem Soc       Date:  2018-07-09       Impact factor: 15.419

5.  Fmoc-Sec(Xan)-OH: synthesis and utility of Fmoc selenocysteine SPPS derivatives with acid-labile sidechain protection.

Authors:  Stevenson Flemer
Journal:  J Pept Sci       Date:  2014-12-11       Impact factor: 1.905

6.  Chemical synthesis of human selenoprotein F and elucidation of its thiol-disulfide oxidoreductase activity.

Authors:  Peisi Liao; Hongmei Liu; Chunmao He
Journal:  Chem Sci       Date:  2022-05-06       Impact factor: 9.969

7.  Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues.

Authors:  Aleksandra Walewska; Tiffany S Han; Min-Min Zhang; Doju Yoshikami; Grzegorz Bulaj; Krzysztof Rolka
Journal:  Eur J Med Chem       Date:  2013-05-01       Impact factor: 6.514

8.  Can Selenoenzymes Resist Electrophilic Modification? Evidence from Thioredoxin Reductase and a Mutant Containing α-Methylselenocysteine.

Authors:  Emma J Ste Marie; Robert J Wehrle; Daniel J Haupt; Neil B Wood; Albert van der Vliet; Michael J Previs; Douglas S Masterson; Robert J Hondal
Journal:  Biochemistry       Date:  2020-08-30       Impact factor: 3.162

9.  Applying selenocysteine-mediated expressed protein ligation to prepare the membrane enzyme selenoprotein S.

Authors:  Rujin Cheng; Jun Liu; Vidyadhar Daithankar; Sharon Rozovsky
Journal:  Methods Enzymol       Date:  2021-12-24       Impact factor: 1.682

10.  Probing pattern and dynamics of disulfide bridges using synthesis and NMR of an ion channel blocker peptide toxin with multiple diselenide bonds.

Authors:  Krisztina Fehér; István Timári; Kinga Rákosi; János Szolomájer; Tünde Z Illyés; Adam Bartok; Zoltan Varga; Gyorgy Panyi; Gábor K Tóth; Katalin E Kövér
Journal:  Chem Sci       Date:  2015-12-21       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.